Skip to main content
Log in

Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Melatonin exists as an active ingredient in several foods and has been reported to inhibit fatty liver disease in animals; however, its molecular mechanisms are not well elucidated. Herein, we explored effects of melatonin on lipid accumulation induced by oleic acid in HepG2 cells and characterized the underlying molecular mechanisms. Pretreatment with melatonin (0.1–0.3 mM) significantly inhibited accumulation of triglyceride and cholesterol induced by incubating HepG2 cells with high concentrations of oleic acid (oleic acid overload) (p < 0.05). Melatonin pretreatment induced phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC), causing their activation and inactivation, respectively. Expression levels of peroxisome proliferator activated receptor-α (PPARα) and its target gene carnitine palmitoyl-CoA transferase 1 (CPT1), which are associated with lipolysis, were upregulated by melatonin, whereas expression of sterol regulatory element binding protein-1c (SREBP-1c), fatty acid synthase (FAS), and stearoyl-CoA desaturase-1 (SCD1), which are associated with lipogenesis, were downregulated. Melatonin did not change expression of genes involved in cholesterol metabolism, including 3-hydroxy-3-methylglutaryl CoA reductase (HMGR) and SREBP-2. Melatonin inhibits lipid accumulation induced by oleic acid overload in HepG2 cells. The phosphorylation and activation of AMPK may have important roles in inactivating lipid anabolic pathways and activating triglyceride catabolic pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Fan, J. G., & Farrell, G. C. (2008). Epidemiology of non-alcoholic fatty liver disease in China. Journal of Hepatology, 50, 204–210.

    Article  Google Scholar 

  2. Ziamajidi, N., Khaghani, S., Hassanzadeh, G., Vardasbi, S., Ahmadian, S., & Nowrouzi, A. et al. (2013). Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. Food and Chemical Toxicology, 58, 198–209.

    Article  CAS  Google Scholar 

  3. Yin, Y., Li, Z., Gao, L., Li, Y., Zhao, J., & Zhang, W. (2015). AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1. Molecular and Cellular Endocrinology, 417, 20–26.

    Article  CAS  Google Scholar 

  4. Dahlhoff, C., Worsch, S., Sailer, M., Hummel, B. A., Fiamoncini, J., & Uebel, K. et al. (2014). Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. Molecular Metabolism, 3, 565–580.

    Article  CAS  Google Scholar 

  5. Foretz, M., & Viollet, B. (2011). Regulation of hepatic metabolism by AMPK. Journal of Hepatology, 54, 827–829.

    Article  Google Scholar 

  6. Serviddio, G., Bellanti, F., & Vendemiale, G. (2013). Free radical biology for medicine: learning from nonalcoholic fatty liver disease. Free Radical Biology for Medicine, 65, 952–968.

    Article  CAS  Google Scholar 

  7. Alonso-Gonzalez, C., Gonzalez, A., Martinez-Campa, C., Menendez-Menendez, J., Gomez-Arozamena, J., & Garcia-Vidal, A. et al. (2016). Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis. Cancer Letters, 370, 145–152.

    Article  CAS  Google Scholar 

  8. Kocadagli, T., Yilmaz, C., & Gokmen, V. (2014). Determination of melatonin and its isomer in foods by liquid chromatography tandem mass spectrometry. Food Chemistry, 153, 151–156.

    Article  CAS  Google Scholar 

  9. Cerezo, A. B., Leal, Á., Álvarez-Fernández, M. A., Hornedo-Ortega, R., Troncoso, A. M., & García-Parrilla, M. C. (2016). Quality control and determination of melatonin in food supplements. Journal of Food Composition and Analysis, 45, 80–86.

    Article  CAS  Google Scholar 

  10. Anwar, M. J., Muhammad, B. Y., Bader, A. A., Abdulghani, M., Mahmood, D., & Haider, M. (2015). An insight into the scientific background and future perspectives for the potential uses of melatonin. Egyptian Journal of Basic and Applied Sciences, 2, 139–152.

    Article  Google Scholar 

  11. She, M., Hou, H., Wang, Z., Zhang, C., Laudon, M., & Yin, W. (2014). Melatonin rescues 3T3-L1 adipocytes from FFA-induced insulin resistance by inhibiting phosphorylation of IRS-1 on Ser307. Biochimie, 103, 126–130.

    Article  CAS  Google Scholar 

  12. Rui, B. B., Chen, H., Jang, L., Li, Z., Yang, J. M., & Xu, W. P. et al. (2015). Melatonin upregulates the activity of AMPK and attenuates lipid accumulation in alcohol-induced rats. Alcohol and Alcoholism, 2015, 51

    Google Scholar 

  13. Hatzis, G., Ziakas, P., Kavantzas, N., Triantafyllou, A., Sigalas, P., & Andreadou, I. et al. (2013). Melatonin attenuates high fat diet-induced fatty liver disease in rats. World Journal of Hepatology, 5, 160–169.

    Article  Google Scholar 

  14. Julia, A., Ramón, R., Videla, L. A., Lilian, T., Myriam, O., & Paulina, P. et al. (2004). Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clinical Science, 106, 635–643.

    Article  Google Scholar 

  15. Cousin, S. P., Hügl, S. R., Wrede, C. E., Kajio, H., Myers, Jr, M. G., & Rhodes, C. J. (2001). Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology, 142, 229–240.

    Article  CAS  Google Scholar 

  16. Chih-Li, L., Hsiu-Chen, H., & Jen-Kun, L. (2007). Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. Journal of Lipid Research, 48, 2334–2343.

    Article  CAS  Google Scholar 

  17. Gorgani-Firuzjaee, S., & Meshkani, R. (2015). SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells. Free Radical Biology and Medicine, 89, 679–689.

    Article  CAS  Google Scholar 

  18. Yao, F., Zhang, M., & Chen, L. (2016). 5’-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications. Acta Pharmaceutica Sinica B, 6, 20–25.

    Article  Google Scholar 

  19. Hardie, D. G., Schaffer, B. E., & Brunet, A. (2016). AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends in Cell Biology, 26, 190–201.

    Article  CAS  Google Scholar 

  20. Janovska, A., Hatzinikolas, G., Staikopoulos, V., Mcinerney, J., Mano, M., & Wittert, G. (2008). AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity. Molecular and Cellular Endocrinology, 284, 1–10.

    Article  CAS  Google Scholar 

  21. Youli, X., Miaozong, W., Hongxia, L., Siqi, D., Erfei, L., & Mingbo, G. et al. (2015). Baicalin attenuates high fat diet-induced obesity and liver dysfunction: dose-response and potential role of CaMKKβ /AMPK/ACC pathway. Cellular Physiology and Biochemistry, 35, 2349–2359.

    Article  CAS  Google Scholar 

  22. Vidyashankar, S., Sharath Kumar, L. M., Barooah, V., Sandeep Varma, R., Nandakumar, K. S., & Patki, P. S. (2012). Liv.52 up-regulates cellular antioxidants and increase glucose uptake to circumvent oleic acid induced hepatic steatosis in HepG2 cells. Phytomedicine, 19, 1156–1165.

    Article  CAS  Google Scholar 

  23. Kim do, Y., Yuan, H. D., Chung, I. K., & Chung, S. H. (2009). Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. Journal of Agricultural Food Chemistry, 57, 1532–1537.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (No. 31570687).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shujuan Ji.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mi, Y., Tan, D., He, Y. et al. Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role. Cell Biochem Biophys 76, 463–470 (2018). https://doi.org/10.1007/s12013-018-0859-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-018-0859-0

Keywords

Navigation